SOSV

InnSight Technology is a biotechnology company focused on advancing the diagnostics and evaluation of eye diseases. The company specializes in developing innovative ophthalmic devices, including a novel, hand-held biosensor designed for the detection of anterior ophthalmic injuries. Additionally, InnSight Technology works on the development of nanotechnology-based medical devices aimed at addressing various clinical needs in ophthalmology. By providing these advanced tools, the company enables clinicians to enhance ocular care and improve patient outcomes in eye health.

Seismi is a veterinary healthcare company specializing in non-invasive, continuous monitoring solutions for pets. Their platform tracks vital signs such as heart rate, respiration, and blood pressure, providing pet owners with real-time, reliable health data, and reducing stress for both pets and owners. Additionally, Seismi offers cattle sensor technology and methane emission analytics, contributing to livestock health management and environmental sustainability.

Founded in 2021, Samphire Neuroscience specializes in developing neurotechnological solutions for women's health. Its flagship product is a non-invasive headband device that uses electrical neuromodulation to alleviate symptoms such as pain, fatigue, and mood changes associated with menstrual cycles.

Founded in 2014, Machine Medicine Technologies develops an AI-powered platform for objective measurement of movement disorders like Parkinson's disease. Using computer vision and pose estimation techniques, it tracks patient movements to provide secure, accessible, and affordable metrics for researchers and healthcare providers.

Sun Genomics, Inc. is a microbiome health company based in San Diego, California, specializing in customized probiotics aimed at addressing dysbiosis. Founded in 2014, the company’s flagship product, Floré, combines a gut microbiome test with personalized probiotic formulations tailored to individual gut profiles, assessed through whole-genome sequencing. The Floré Gut Test includes a microflora collection kit, a comprehensive microflora profile analysis, and wellness consultations. Additionally, Sun Genomics offers Floré Tots, a probiotic solution designed for children up to age 12, which comes in a convenient powder form that can be easily mixed with beverages. The company sells its products online, providing an automatic renewal service to enhance customer convenience.

ZiO Health is a biotechnology company that develops pocket-sized devices featuring proprietary biosensor technology and machine learning algorithms. These devices enable real-time laboratory testing at the point-of-care, enhancing patient care by combining immediate results with individual patient profiles.

Oobli is a food company focused on developing innovative protein sweeteners derived from exotic plants. These unique sweeteners offer a delicious taste while significantly reducing calories, making them a healthier alternative to traditional sugars. Produced through fermentation, Oobli's sweeteners have no glycemic impact and do not influence the gut microbiome, allowing consumers to enjoy sweetness without concerns related to blood sugar, insulin, or weight management. The company has successfully obtained regulatory approvals, including FDA "no questions" letters and GRAS status for multiple protein sources, which positions it as a leader in the healthy sweetener market. By transforming flavors, Oobli aims to enhance everyday food experiences while promoting better health outcomes for its users.

VALANX Biotech GmbH is an innovative biotechnology company based in Klosterneuburg, Austria, founded in 2017. The company specializes in the development and manufacturing of synthetic programmable amino acids, notably Norl, and the reactive amino acid SnapIt. These products are designed to facilitate the creation of antibody-drug conjugates, which enhance cancer treatment by selectively targeting cancer cells. VALANX Biotech’s platform also supports PEGylation of therapeutic peptides and proteins, as well as the directed and oriented immobilization of biosensors and biocatalysts. Additionally, the company offers bioanalytics and mass spectrometry services on demand, helping to streamline the development of site-specific protein-drug conjugates in a cost-effective manner.

Founded in 2015, GlowDx specializes in developing point-of-care diagnostic platforms. Utilizing novel molecular technology and machine learning, the company aims to democratize access to diagnostics globally, enabling timely detection of infectious diseases and reducing disease burden.

EIO Diagnostics Inc. is a Canadian company specializing in udder health technology for dairy farming. Founded in 2017 and based in Duncan, it develops the FirstLook Mastitis detection system, which aims to prevent mastitis infections in dairy animals. The system employs a multispectral sensor installed at the entrance of the milk parlor to capture images of the udder as cows enter, enabling early detection of infection indicators through advanced infrared image analysis and computer vision. This technology automates the screening process, allowing farmers to monitor udder health efficiently, reduce labor costs, and enhance milk quality.

FeetMe is a digital health company that develops a platform and connected footwear insoles for gait and movement analysis in-clinic and real-world settings. The technology combines pressure sensors, motion data, and learning algorithms to provide real-time gait and posture insights and digital biomarkers to support clinical research and improve care for patients with movement disorders and mobility constraints. These insights enable clinicians to monitor disease progression, tailor treatments, and optimize medication use by assessing mobility capacity and tracking changes over time.

Lief Therapeutics is a medical device company based in San Francisco, California, focused on enhancing at-home care for individuals dealing with post-traumatic stress disorder, depression, and anxiety. The company has developed a discreet bio-sensing patch that accurately measures heart rate and breath, allowing users to manage their natural stress response through vibratory biofeedback exercises. This wearable device helps users monitor their behaviors, emotions, and thoughts in real-time, fostering mindfulness and control throughout the day. Additionally, it supports clinicians by tracking patient progress, facilitating in-session training, and scheduling psychological assessments. Lief Therapeutics also offers the Lief Health Score application, which records thoughts, emotions, and sensations, enabling users to track daily progress and engage in tailored exercises. Founded in 2014, the company sells its products online, aiming to empower individuals in their mental health journeys.

Flowbio is a wellness and fitness services company that specializes in developing a real-time hydration biosensor platform aimed at athletes, including triathletes, cyclists, and runners. The company offers a wearable, non-invasive patch that monitors the body's hydration status by analyzing sweat at a molecular level. This technology captures critical biomarkers, such as electrolytes and total body fluid loss, providing users with personalized recommendations to enhance their athletic performance. By focusing on hydration management, Flowbio seeks to support athletes in optimizing their training and maintaining peak physical condition.

Strados Labs, LLC is a medical technology company based in Philadelphia, Pennsylvania, specializing in respiratory health management through innovative sensor-based solutions. Founded in 2016, the company has developed a wearable device that provides real-time insights into breathing patterns, sounds, and speed. This device is equipped with clinical-grade biosensors and smart software, allowing for continuous monitoring of respiratory conditions such as asthma and chronic obstructive pulmonary disease. By connecting to a mobile application, Strados enables users and healthcare providers to access and analyze respiratory data, facilitating informed health decisions and remote patient monitoring.

Founded in 2021, Samphire Neuroscience specializes in developing neurotechnological solutions for women's health. Its flagship product is a non-invasive headband device that uses electrical neuromodulation to alleviate symptoms such as pain, fatigue, and mood changes associated with menstrual cycles.

Sun Genomics, Inc. is a microbiome health company based in San Diego, California, specializing in customized probiotics aimed at addressing dysbiosis. Founded in 2014, the company’s flagship product, Floré, combines a gut microbiome test with personalized probiotic formulations tailored to individual gut profiles, assessed through whole-genome sequencing. The Floré Gut Test includes a microflora collection kit, a comprehensive microflora profile analysis, and wellness consultations. Additionally, Sun Genomics offers Floré Tots, a probiotic solution designed for children up to age 12, which comes in a convenient powder form that can be easily mixed with beverages. The company sells its products online, providing an automatic renewal service to enhance customer convenience.

Lura Health develops a non-invasive continuous health monitoring platform that uses saliva as a diagnostic fluid. The company integrates micro-sensors into orthodontic devices such as retainers, aligners, and brackets to continuously measure saliva analytes and securely transmit data to a smartphone app, enabling users to monitor oral health metrics and potentially support broader chronic disease management. Target markets include heart disease, chronic kidney disease, diabetes, and tooth decay. Founded in 2017, the company is based in Cambridge, Massachusetts.

Hypercell Technologies specializes in developing innovative tools for controlling infectious diseases in animals. The company's core focus is on creating rapid, accurate diagnostic tools using molecular biology techniques, which enable veterinarians to detect and manage infections swiftly. Additionally, Hypercell develops monoclonal antibodies designed to proactively control viruses in production animal reservoirs, aiming to prevent potential zoonotic disease outbreaks in humans by addressing the source in animals.

VALANX Biotech GmbH is an innovative biotechnology company based in Klosterneuburg, Austria, founded in 2017. The company specializes in the development and manufacturing of synthetic programmable amino acids, notably Norl, and the reactive amino acid SnapIt. These products are designed to facilitate the creation of antibody-drug conjugates, which enhance cancer treatment by selectively targeting cancer cells. VALANX Biotech’s platform also supports PEGylation of therapeutic peptides and proteins, as well as the directed and oriented immobilization of biosensors and biocatalysts. Additionally, the company offers bioanalytics and mass spectrometry services on demand, helping to streamline the development of site-specific protein-drug conjugates in a cost-effective manner.

RizLab Health is a medical device startup founded in 2018 and based in East Princeton. The company specializes in providing rapid blood count analysis through its innovative electronic cytometer and analyzer. This device utilizes a cartridge system to quantify key cellular components of white blood cells, facilitating quick and accurate assessments of patients' health. RizLab Health's technology is designed to be portable and cost-effective, enabling healthcare practitioners to monitor white blood counts, neutrophils, and lymphocytes efficiently. This capability is particularly valuable in clinical scenarios such as diagnosing sepsis or determining the presence of bacterial or viral infections, enhancing decision-making in patient care.

BioAesthetics develops tissue-engineered nipple-areolar complex grafts to support breast reconstruction after mastectomy. The graft is designed as a scaffold for the patient's own cells to populate and regenerate the nipple and areola during reconstruction, aiming to improve cosmetic and reconstructive outcomes. The company originated as a Tulane University spin-out and was founded in 2015.

LightHearted AI is a company that specializes in developing an AI-driven remote cardiovascular diagnostics tool aimed at improving the detection of heart conditions. This medical device is designed to deliver rapid, precise, and cost-effective assessments, addressing the critical need to prevent heart-related deaths. By leveraging advanced technology, LightHearted AI enhances the capabilities of healthcare professionals, allowing for faster and more accurate diagnostic procedures compared to traditional methods. The company's innovation seeks to transform cardiac care, ultimately contributing to better treatment outcomes for patients.

MedIQ is an integrated virtual care platform providing on-demand healthcare at the point of need. MedIQ redefines healthcare through a digitally enabled, cashless, hybrid healthcare ecosystem. MedIQ makes high-quality, modernized healthcare and wellness available to everyone.

Liberum Biotech is a biotechnology company focused on advancing protein manufacturing through proprietary molecular and hardware technologies. Its platform facilitates the rapid production of enzymes, therapeutics, and laboratory reagents, enabling clients to enhance speed and scalability while significantly reducing costs. By leveraging its innovative protein synthesizers, Liberum aims to democratize access to synthetic biology, ultimately transforming existing biologics manufacturing practices and making these technologies more accessible to a broader range of users.

VALANX Biotech GmbH is an innovative biotechnology company based in Klosterneuburg, Austria, founded in 2017. The company specializes in the development and manufacturing of synthetic programmable amino acids, notably Norl, and the reactive amino acid SnapIt. These products are designed to facilitate the creation of antibody-drug conjugates, which enhance cancer treatment by selectively targeting cancer cells. VALANX Biotech’s platform also supports PEGylation of therapeutic peptides and proteins, as well as the directed and oriented immobilization of biosensors and biocatalysts. Additionally, the company offers bioanalytics and mass spectrometry services on demand, helping to streamline the development of site-specific protein-drug conjugates in a cost-effective manner.

Founded in 2021, Samphire Neuroscience specializes in developing neurotechnological solutions for women's health. Its flagship product is a non-invasive headband device that uses electrical neuromodulation to alleviate symptoms such as pain, fatigue, and mood changes associated with menstrual cycles.

Care Constitution operates a telehealth platform that facilitates remote medical consultations. It uses AI to analyze sound and images during virtual appointments, generating real-time clinical data and automated assessments for healthcare providers.

OpenShelf is a company founded in 2023 that specializes in inventory automation for optometrists. It has developed a unique system that incorporates robotic technology to manage and distribute thousands of different contact lens boxes. This innovative "vending machine" style solution simplifies the inventory management process, allowing optometrists to efficiently handle, sort, and disperse contact lenses. Additionally, OpenShelf's software provides valuable data insights that help practitioners determine optimal reordering times for specific prescriptions and maintain appropriate stock levels.

Renegade.bio is a biotechnology startup focused on the development and deployment of high-throughput diagnostics aimed at detecting novel infectious diseases. The company specializes in creating innovative diagnostics and assays that support drug development, utilizing advanced techniques such as biomarker discovery, polymerase chain reaction (PCR), next-generation sequencing (NGS), and liquid chromatography-mass spectrometry (LC-MS). By leveraging these capabilities, Renegade.bio enables healthcare organizations to offer diagnostic testing across various settings, including individuals, workplaces, schools, communities, and large events.

Moirai Biodesign is a biotechnology company focused on developing RNA-based therapies and diagnostics for cancer. Founded in 2016, the company operates from Barcelona, Spain, and specializes in creating non-invasive tests for in-situ diagnosis of various cancers using patient blood samples. Additionally, it provides in-vivo diagnosis systems that assist in surgeries and facilitate patient monitoring. Moirai Biodesign's portfolio includes the discovery of RNA biomarkers, the design of plug-and-play bio devices, and a platform for delivering therapeutic drugs aimed at treating cancer. By advancing these technologies, the company aims to enhance early cancer detection and improve treatment outcomes.

Dia has invented an electrochemical sensor that can measure a wide variety of chemical biomarkers non-invasively in saliva or sweat. The data is sent via Bluetooth to an app on the user’s smartphone and analyzed in real-time. From the app, it can be securely sent to a third party. To date, we have measured hormones, electrolytes, neurotransmitters and metabolites. At DIA, we let the biology dictate which analyte we put on which platform – our wearable arm sleeve for sweat or our table-top device for saliva – because some biomarkers, such as cortisol fluctuate throughout the day and need to be monitored through a wearable sensor, while others, such as creatinine are more suitable to a daily saliva test.

BiomeSense develops an integrated hardware, software, and data platform to scale microbiome data collection and analysis for clinical research. The company integrates at-home monitoring of the gut microbiome through its GutLab smart-bathroom system with the MetaBiome time-series analytics platform to connect microbiome changes with clinical outcomes in real time. Its platform supports large-scale, densely longitudinal datasets to discover, validate, and commercialize microbiome biomarkers, enabling clinicians to apply microbiome insights to improve human health. Founded in 2018 and based in Chicago, BiomeSense seeks to advance precision medicine by providing end-to-end microbiome measurement and analytics.

Renegade.bio is a biotechnology startup focused on the development and deployment of high-throughput diagnostics aimed at detecting novel infectious diseases. The company specializes in creating innovative diagnostics and assays that support drug development, utilizing advanced techniques such as biomarker discovery, polymerase chain reaction (PCR), next-generation sequencing (NGS), and liquid chromatography-mass spectrometry (LC-MS). By leveraging these capabilities, Renegade.bio enables healthcare organizations to offer diagnostic testing across various settings, including individuals, workplaces, schools, communities, and large events.

Lief Therapeutics is a medical device company based in San Francisco, California, focused on enhancing at-home care for individuals dealing with post-traumatic stress disorder, depression, and anxiety. The company has developed a discreet bio-sensing patch that accurately measures heart rate and breath, allowing users to manage their natural stress response through vibratory biofeedback exercises. This wearable device helps users monitor their behaviors, emotions, and thoughts in real-time, fostering mindfulness and control throughout the day. Additionally, it supports clinicians by tracking patient progress, facilitating in-session training, and scheduling psychological assessments. Lief Therapeutics also offers the Lief Health Score application, which records thoughts, emotions, and sensations, enabling users to track daily progress and engage in tailored exercises. Founded in 2014, the company sells its products online, aiming to empower individuals in their mental health journeys.

SAVA develops advanced biosensing technology for painless, real-time, and affordable health monitoring. Their innovative solutions enable continuous tracking of glucose and lactate levels, empowering users with real-time bodily insights to optimize performance and nutrition.

Founded in 2013, Aluna develops a portable spirometry device paired with an interactive iPhone game. Its health platform helps users track asthma symptoms, monitor medication, and provides real-time data sharing with doctors for personalized treatment plans.

Sun Genomics, Inc. is a microbiome health company based in San Diego, California, specializing in customized probiotics aimed at addressing dysbiosis. Founded in 2014, the company’s flagship product, Floré, combines a gut microbiome test with personalized probiotic formulations tailored to individual gut profiles, assessed through whole-genome sequencing. The Floré Gut Test includes a microflora collection kit, a comprehensive microflora profile analysis, and wellness consultations. Additionally, Sun Genomics offers Floré Tots, a probiotic solution designed for children up to age 12, which comes in a convenient powder form that can be easily mixed with beverages. The company sells its products online, providing an automatic renewal service to enhance customer convenience.

Untap Health develops a real-time wastewater monitoring system that detects and tracks infectious diseases. Its platform analyzes samples from commercial sites, schools, and healthcare facilities to identify potential outbreaks early, empowering organizations with actionable insights for effective disease prevention.

Bisu is a health technology company that offers a home health lab designed to enhance personal well-being through urine and saliva tests. Its devices monitor various health metrics, including dietary health, fat metabolism, and hydration levels, providing users with daily feedback on electrolytes, hydration, pH, ketones, and uric acid via a mobile application. This functionality enables individuals to track burned body fat, maintain metabolic health, achieve optimal ketosis, and improve physical endurance. Bisu has received recognition for its innovation, having been awarded by prestigious organizations such as Johnson & Johnson Innovation and MedTech Innovator, and it gained further acclaim at CES 2020 with the IHS Markit Innovation Award.

Free to Feed is a company focused on enhancing breastfeeding experiences by providing solutions for detecting food allergens in breast milk. It offers an innovative over-the-counter allergen test that empowers breastfeeding mothers to identify various food proteins in their milk, which is crucial for those concerned about potential infant food allergies or intolerances. The company’s patented testing kits, combined with a mobile application, allow mothers to document the presence of allergens, the timing of milk expression, and any symptoms their infants may exhibit. This comprehensive data collection aids medical professionals in diagnosing and managing food allergies effectively. With a growing recognition of the importance of early allergen introduction to mitigate future allergies, Free to Feed supports parents in navigating these complexities with tailored counseling and technology, ensuring they can confidently meet their breastfeeding goals while safeguarding their infants' health.

ChektAhora is a Latin American company specializing in at-home testing kits for sexually transmitted infections (STIs). Their platform offers confidential, convenient, and pain-free testing solutions, utilizing PCR tests to identify STIs and other infectious diseases like influenza and COVID-19. The company aims to provide accessible healthcare services directly to customers' homes or offices.

Sun Genomics, Inc. is a microbiome health company based in San Diego, California, specializing in customized probiotics aimed at addressing dysbiosis. Founded in 2014, the company’s flagship product, Floré, combines a gut microbiome test with personalized probiotic formulations tailored to individual gut profiles, assessed through whole-genome sequencing. The Floré Gut Test includes a microflora collection kit, a comprehensive microflora profile analysis, and wellness consultations. Additionally, Sun Genomics offers Floré Tots, a probiotic solution designed for children up to age 12, which comes in a convenient powder form that can be easily mixed with beverages. The company sells its products online, providing an automatic renewal service to enhance customer convenience.

Melio is a healthcare company based in Santa Clara, California, specializing in blood testing technology aimed at detecting prevalent infections. The company has developed a comprehensive blood test platform that identifies common pathogens responsible for bloodstream infections. Utilizing a patented melting technique followed by detailed analysis, Melio's technology enables quick and accurate identification of blood-based pathogens. This innovation allows healthcare providers to deliver timely and targeted treatment, addressing the urgent need for effective therapies while also contributing to the fight against antibiotic resistance.

Founded in 2021, Samphire Neuroscience specializes in developing neurotechnological solutions for women's health. Its flagship product is a non-invasive headband device that uses electrical neuromodulation to alleviate symptoms such as pain, fatigue, and mood changes associated with menstrual cycles.

Founded in 2014, Machine Medicine Technologies develops an AI-powered platform for objective measurement of movement disorders like Parkinson's disease. Using computer vision and pose estimation techniques, it tracks patient movements to provide secure, accessible, and affordable metrics for researchers and healthcare providers.

Chronos DX is a biotechnology research company based in London, Germany, specializing in drug development and in vitro diagnostics within the healthcare sector. The company is known for its innovative bioassay technology, which is designed for diagnostics, drug screening, and development. Chronos DX focuses on creating high-performance, low-cost, and scalable technology capable of detecting a variety of biomarkers, including cell-free DNA, micro proteins, exosomes, and metabolites. This technology provides medical professionals with a platform for in-line and in vivo monitoring of biomarkers, enhancing the capabilities of diagnostics and drug development in medical practice.

Founded in 2015, GlowDx specializes in developing point-of-care diagnostic platforms. Utilizing novel molecular technology and machine learning, the company aims to democratize access to diagnostics globally, enabling timely detection of infectious diseases and reducing disease burden.

Moirai Biodesign is a biotechnology company focused on developing RNA-based therapies and diagnostics for cancer. Founded in 2016, the company operates from Barcelona, Spain, and specializes in creating non-invasive tests for in-situ diagnosis of various cancers using patient blood samples. Additionally, it provides in-vivo diagnosis systems that assist in surgeries and facilitate patient monitoring. Moirai Biodesign's portfolio includes the discovery of RNA biomarkers, the design of plug-and-play bio devices, and a platform for delivering therapeutic drugs aimed at treating cancer. By advancing these technologies, the company aims to enhance early cancer detection and improve treatment outcomes.

Paragon Pure is a food ingredient company specializing in developing natural products that cater to modern dietary needs. They focus on areas such as flavor encapsulation and process engineering, leveraging physical chemistry principles and navigating regulatory spaces to create healthier, sustainable structured fats and flavors.

EIO Diagnostics Inc. is a Canadian company specializing in udder health technology for dairy farming. Founded in 2017 and based in Duncan, it develops the FirstLook Mastitis detection system, which aims to prevent mastitis infections in dairy animals. The system employs a multispectral sensor installed at the entrance of the milk parlor to capture images of the udder as cows enter, enabling early detection of infection indicators through advanced infrared image analysis and computer vision. This technology automates the screening process, allowing farmers to monitor udder health efficiently, reduce labor costs, and enhance milk quality.

Kinexcs is an AI-driven health technology company focused on improving mobility and quality of life for individuals with musculoskeletal conditions. It offers a digital therapy solution comprising KIMIA, the world's first continuous knee health monitor, and an AI-based digital therapist for convenient and cost-effective access to therapy.

PONS is a company specializing in the development of artificial intelligence to enhance ultrasound imaging, particularly for brain diagnostics. Utilizing machine learning algorithms, PONS transforms traditional ultrasound systems into smart, AI-driven diagnostic tools that improve scan resolution, tissue contrast, and noise reduction. This innovation aims to provide expert-level insights without the need for costly new hardware. The company's primary objective is to create a wearable ultrasound device to assist first responders and ambulance doctors with pre-diagnostics in challenging circumstances, facilitating early disease detection and preventive screening. By focusing on important anatomical features in ultrasound scans, PONS seeks to advance the capabilities of ultrasound technology in neurosurgery and related fields.

Oobli is a food company focused on developing innovative protein sweeteners derived from exotic plants. These unique sweeteners offer a delicious taste while significantly reducing calories, making them a healthier alternative to traditional sugars. Produced through fermentation, Oobli's sweeteners have no glycemic impact and do not influence the gut microbiome, allowing consumers to enjoy sweetness without concerns related to blood sugar, insulin, or weight management. The company has successfully obtained regulatory approvals, including FDA "no questions" letters and GRAS status for multiple protein sources, which positions it as a leader in the healthy sweetener market. By transforming flavors, Oobli aims to enhance everyday food experiences while promoting better health outcomes for its users.

Flowbio is a wellness and fitness services company that specializes in developing a real-time hydration biosensor platform aimed at athletes, including triathletes, cyclists, and runners. The company offers a wearable, non-invasive patch that monitors the body's hydration status by analyzing sweat at a molecular level. This technology captures critical biomarkers, such as electrolytes and total body fluid loss, providing users with personalized recommendations to enhance their athletic performance. By focusing on hydration management, Flowbio seeks to support athletes in optimizing their training and maintaining peak physical condition.

Aksense is a biotechnology company focused on developing affordable and portable nucleic acid-based diagnostic panels for the rapid and accurate detection of pathogens. It has created the first portable rapid infection diagnostic biosensor designed to enhance the quality of care in healthcare settings. Aksense aims to improve antibiotic prescribing practices and public health outcomes by enabling early detection and treatment of infections. Its technology facilitates faster recovery for patients through cost-effective molecular testing, ultimately reducing the spread of infections and improving overall patient outcomes.

AnimalBiome specializes in personalized pet nutrition, focusing on improving gut health for dogs and cats through microbiome science. The company offers microbiome tests to analyze pets' gut bacteria and provides tailored restorative supplements sourced from healthy animals to balance the microbiome.

Portable Diagnostic Systems, established in August 2019, specializes in developing a microfluidics-based drug testing platform tailored for law enforcement agencies. Their innovative solution enables swift and accurate roadside saliva tests, reducing the need for guesswork during impaired driving traffic stops. The company's platform leverages salivary diagnostics, antibody engineering, and microfluidics to deliver precise results from small samples, thereby minimizing false positives and enhancing public safety.

Founded in 2019, Kalia Health is a biotechnology company based in Chapel Hill, North Carolina. It develops affordable and accessible home-based early detection tests to improve maternal health outcomes.

Zennea Technologies is a medical device company based in Surrey, Canada, specializing in the development of therapeutic wearables aimed at reducing snoring and improving overall health through enhanced sleep quality. The company's flagship product, ZENS, is a comfortable and discreet sleep wearable that targets the root cause of snoring, thereby assisting individuals with chronic snoring and mild obstructive sleep apnea. Zennea conducts clinical trials to validate the efficacy of its device, which not only helps reduce snoring but also tracks sleep quality, providing valuable insights for users to make informed decisions about their health and sleep habits.

PhableCare creates an ecosystem of patients, doctors, hospitals, health devices, insurance, and patient care service providers. In India, 1 in 4 people suffer from chronic ailments. Meanwhile, 80% of patients cannot comply to the treatment plan provided by the doctor leading to even more complications. This poses a huge burden on the healthcare system. Phable solves this by making care autonomous and predictive. Our AI-enabled health assistant significantly improves health outcomes by enabling disease-specific guidance and continuous monitoring.

FoodMarble is a company focused on addressing the needs of individuals suffering from digestive issues, a challenge that affects nearly one billion people worldwide. It has developed the AIRE device, a personal breath analyzer that assists users in identifying foods that align with their unique digestive systems. By utilizing techniques found in gastroenterology, AIRE enables real-time tracking of digestive responses to various foods through a handheld, affordable device and an accompanying application. This innovative approach allows users to craft personalized diets that can alleviate discomfort and improve overall well-being. FoodMarble has garnered significant interest, with over $500,000 in pre-orders, and aims to create a comprehensive dataset to enhance understanding of digestive health.

Conan MedTech, founded in 2020 and based in Ithaca, New York, is focused on developing rapid point-of-care diagnostic tests for concussions. The company's innovative healthcare system aims to transform the diagnosis of mild traumatic brain injuries, enabling sports medicine doctors, athletic coaches, and trainers to make informed decisions on the sidelines during games. By providing real-time concussion detection and efficient medical assistance, Conan MedTech enhances the ability of medical professionals to assess athletes swiftly and improve their quality of life through timely interventions.

Conan MedTech, founded in 2020 and based in Ithaca, New York, is focused on developing rapid point-of-care diagnostic tests for concussions. The company's innovative healthcare system aims to transform the diagnosis of mild traumatic brain injuries, enabling sports medicine doctors, athletic coaches, and trainers to make informed decisions on the sidelines during games. By providing real-time concussion detection and efficient medical assistance, Conan MedTech enhances the ability of medical professionals to assess athletes swiftly and improve their quality of life through timely interventions.

Founded in 2019, Kalia Health is a biotechnology company based in Chapel Hill, North Carolina. It develops affordable and accessible home-based early detection tests to improve maternal health outcomes.

Harae Dx Corp. is a medical diagnostics company that has created a compact and portable multi-cancer detection system. This innovative platform enables automated cancer diagnostics by detecting cancer biomarkers directly, eliminating the need to send specimens to third-party laboratories. By reducing the potential for human processing errors and improving turnaround times for results, Harae Dx's technology allows healthcare professionals to identify and treat cancer at an early stage more effectively and affordably.

FeetMe is a digital health company that develops a platform and connected footwear insoles for gait and movement analysis in-clinic and real-world settings. The technology combines pressure sensors, motion data, and learning algorithms to provide real-time gait and posture insights and digital biomarkers to support clinical research and improve care for patients with movement disorders and mobility constraints. These insights enable clinicians to monitor disease progression, tailor treatments, and optimize medication use by assessing mobility capacity and tracking changes over time.

PONS is a company specializing in the development of artificial intelligence to enhance ultrasound imaging, particularly for brain diagnostics. Utilizing machine learning algorithms, PONS transforms traditional ultrasound systems into smart, AI-driven diagnostic tools that improve scan resolution, tissue contrast, and noise reduction. This innovation aims to provide expert-level insights without the need for costly new hardware. The company's primary objective is to create a wearable ultrasound device to assist first responders and ambulance doctors with pre-diagnostics in challenging circumstances, facilitating early disease detection and preventive screening. By focusing on important anatomical features in ultrasound scans, PONS seeks to advance the capabilities of ultrasound technology in neurosurgery and related fields.

Free to Feed is a company focused on enhancing breastfeeding experiences by providing solutions for detecting food allergens in breast milk. It offers an innovative over-the-counter allergen test that empowers breastfeeding mothers to identify various food proteins in their milk, which is crucial for those concerned about potential infant food allergies or intolerances. The company’s patented testing kits, combined with a mobile application, allow mothers to document the presence of allergens, the timing of milk expression, and any symptoms their infants may exhibit. This comprehensive data collection aids medical professionals in diagnosing and managing food allergies effectively. With a growing recognition of the importance of early allergen introduction to mitigate future allergies, Free to Feed supports parents in navigating these complexities with tailored counseling and technology, ensuring they can confidently meet their breastfeeding goals while safeguarding their infants' health.

Inso Biosciences is an early-stage biotechnology company focused on developing innovative hardware platforms and tools for genomic sample handling. Utilizing patented microfluidic technology originally invented at Cornell University, Inso Biosciences enhances the efficiency of processing cellular material. The company's platform is designed to facilitate genomic analysis, including applications in long-read DNA extraction, multiomic sample processing, and pathogen surveillance. By enabling healthcare and biotechnology companies to effectively separate and isolate cellular components, Inso Biosciences aims to transform the landscape of biological sample preparation.

VemiCo is a biotechnology company focused on extending healthy living by addressing the aging process. The company leverages artificial intelligence and synthetic biology to discover and advance promising molecules derived from gut microbial DNA. By harnessing the potential of microbiomes, VemiCo aims to enhance gut health and overall well-being, offering innovative solutions for medical professionals in the health sector.

Hydrostasis develops a hydration monitor system for athletes to reach and maintain peak performance. The wearable sensors measure each athlete's optimal hydration range based on body composition and provide preventive notifications before dehydration symptoms affect performance. Based in San Diego, California, Hydrostasis collaborates with device manufacturers in both consumer and clinical applications to enable hydration monitoring capabilities. The company delivers personalized information with device-agnostic and clinical-grade accuracy and uses cloud-based data storage to deliver real-time, actionable hydration insights, enabling athletes to track their hydration ranges and sustain optimal performance.

VALANX Biotech GmbH is an innovative biotechnology company based in Klosterneuburg, Austria, founded in 2017. The company specializes in the development and manufacturing of synthetic programmable amino acids, notably Norl, and the reactive amino acid SnapIt. These products are designed to facilitate the creation of antibody-drug conjugates, which enhance cancer treatment by selectively targeting cancer cells. VALANX Biotech’s platform also supports PEGylation of therapeutic peptides and proteins, as well as the directed and oriented immobilization of biosensors and biocatalysts. Additionally, the company offers bioanalytics and mass spectrometry services on demand, helping to streamline the development of site-specific protein-drug conjugates in a cost-effective manner.

Founded in 2021, Samphire Neuroscience specializes in developing neurotechnological solutions for women's health. Its flagship product is a non-invasive headband device that uses electrical neuromodulation to alleviate symptoms such as pain, fatigue, and mood changes associated with menstrual cycles.

Criam is a Portuguese biotechnology company based in Braga that develops portable diagnostic technology for blood typing and infectious disease detection. Its stand-alone platform does not require electricity or laboratory infrastructure, enabling rapid testing at the point of care. A single reader can perform multiple tests using cartridges and computer vision algorithms to detect a broad range of diseases, including HIV, with real-time data to support clinical decisions. The system leverages lab-on-a-chip concepts and biomarker detection algorithms to deliver fast, user-friendly, and cost-effective diagnostics in diverse settings, including remote environments and emergency care.

Intelligent Implants is a bioelectronics company developing an implantable electrical stimulation platform that uses wireless devices to stimulate, steer, and monitor bone growth and tissue recovery. The company designs electrotherapeutic medical devices intended to treat diseases and accelerate healing in bone and other tissues. Its implants enable healthcare providers to control and monitor treatment, supporting decision making in patient care. By integrating data, engineering and medicine, Intelligent Implants aims to bring active, connected medical devices to clinical practice, improving outcomes for individuals with bone conditions and related injuries.

Sequential Skin is a diagnostic platform focused on skin longevity and aging, leveraging expertise in genetics, epigenetics, and the skin microbiome. The company specializes in clinical microbiome testing for skin, scalp, and female health. Its primary offering is a skin health test that employs quantitative real-time PCR (qPCR) technology to analyze specific markers within the skin microbiome. This analysis provides individuals with a detailed understanding of their skin profile, helping them identify their unique skincare needs. By delivering personalized insights, Sequential Skin empowers individuals to make informed decisions about their skincare routines.

Bisu is a health technology company that offers a home health lab designed to enhance personal well-being through urine and saliva tests. Its devices monitor various health metrics, including dietary health, fat metabolism, and hydration levels, providing users with daily feedback on electrolytes, hydration, pH, ketones, and uric acid via a mobile application. This functionality enables individuals to track burned body fat, maintain metabolic health, achieve optimal ketosis, and improve physical endurance. Bisu has received recognition for its innovation, having been awarded by prestigious organizations such as Johnson & Johnson Innovation and MedTech Innovator, and it gained further acclaim at CES 2020 with the IHS Markit Innovation Award.

Sequential Skin is a diagnostic platform focused on skin longevity and aging, leveraging expertise in genetics, epigenetics, and the skin microbiome. The company specializes in clinical microbiome testing for skin, scalp, and female health. Its primary offering is a skin health test that employs quantitative real-time PCR (qPCR) technology to analyze specific markers within the skin microbiome. This analysis provides individuals with a detailed understanding of their skin profile, helping them identify their unique skincare needs. By delivering personalized insights, Sequential Skin empowers individuals to make informed decisions about their skincare routines.

Paragon Pure is a food ingredient company specializing in developing natural products that cater to modern dietary needs. They focus on areas such as flavor encapsulation and process engineering, leveraging physical chemistry principles and navigating regulatory spaces to create healthier, sustainable structured fats and flavors.

RizLab Health is a medical device startup founded in 2018 and based in East Princeton. The company specializes in providing rapid blood count analysis through its innovative electronic cytometer and analyzer. This device utilizes a cartridge system to quantify key cellular components of white blood cells, facilitating quick and accurate assessments of patients' health. RizLab Health's technology is designed to be portable and cost-effective, enabling healthcare practitioners to monitor white blood counts, neutrophils, and lymphocytes efficiently. This capability is particularly valuable in clinical scenarios such as diagnosing sepsis or determining the presence of bacterial or viral infections, enhancing decision-making in patient care.

RizLab Health is a medical device startup founded in 2018 and based in East Princeton. The company specializes in providing rapid blood count analysis through its innovative electronic cytometer and analyzer. This device utilizes a cartridge system to quantify key cellular components of white blood cells, facilitating quick and accurate assessments of patients' health. RizLab Health's technology is designed to be portable and cost-effective, enabling healthcare practitioners to monitor white blood counts, neutrophils, and lymphocytes efficiently. This capability is particularly valuable in clinical scenarios such as diagnosing sepsis or determining the presence of bacterial or viral infections, enhancing decision-making in patient care.

Untap Health develops a real-time wastewater monitoring system that detects and tracks infectious diseases. Its platform analyzes samples from commercial sites, schools, and healthcare facilities to identify potential outbreaks early, empowering organizations with actionable insights for effective disease prevention.

Microgenesis is a biotechnology company focused on fertility and pregnancy health monitoring. It has developed a platform that provides a non-invasive fertility test and personalized nutritional supplementation aimed at restoring women's fertility potential. The company's innovative diagnostic approach detects subclinical inflammation that negatively impacts ovarian function and implantation, specifically targeting women who have experienced challenges, including multiple failed IVF attempts. Operating out of a CLIA lab in Oakland, Microgenesis offers its solutions through OB-GYNs and direct-to-consumer channels. Additionally, the platform addresses imbalances in vaginal and intestinal microbiota linked to infertility and offers dual testing for immunological issues related to the endometrium, equipping patients with effective treatment options for complex reproductive health cases.

EIO Diagnostics Inc. is a Canadian company specializing in udder health technology for dairy farming. Founded in 2017 and based in Duncan, it develops the FirstLook Mastitis detection system, which aims to prevent mastitis infections in dairy animals. The system employs a multispectral sensor installed at the entrance of the milk parlor to capture images of the udder as cows enter, enabling early detection of infection indicators through advanced infrared image analysis and computer vision. This technology automates the screening process, allowing farmers to monitor udder health efficiently, reduce labor costs, and enhance milk quality.

Strados Labs, LLC is a medical technology company based in Philadelphia, Pennsylvania, specializing in respiratory health management through innovative sensor-based solutions. Founded in 2016, the company has developed a wearable device that provides real-time insights into breathing patterns, sounds, and speed. This device is equipped with clinical-grade biosensors and smart software, allowing for continuous monitoring of respiratory conditions such as asthma and chronic obstructive pulmonary disease. By connecting to a mobile application, Strados enables users and healthcare providers to access and analyze respiratory data, facilitating informed health decisions and remote patient monitoring.

RxAll, Inc. is a technology company that specializes in developing an artificial intelligence-driven platform for the authentication and distribution of pharmaceuticals, primarily in Africa. Founded in 2015 and headquartered in New Haven, Connecticut, the company utilizes a deep learning hyperspectral Internet of Things (IoT) platform that incorporates a molecular sensor device and a cloud database of spectral signatures. This innovative approach allows for non-destructive authentication of medications, including prescription and over-the-counter drugs, before they are dispensed. RxAll aims to combat the issue of counterfeit drugs by providing real-time information to pharmaceutical manufacturers about the authenticity of their products. Additionally, the platform facilitates access to authenticated medicines for patients and pharmacies, while also offering tele-pharmacy primary care services.

Sequential Skin is a diagnostic platform focused on skin longevity and aging, leveraging expertise in genetics, epigenetics, and the skin microbiome. The company specializes in clinical microbiome testing for skin, scalp, and female health. Its primary offering is a skin health test that employs quantitative real-time PCR (qPCR) technology to analyze specific markers within the skin microbiome. This analysis provides individuals with a detailed understanding of their skin profile, helping them identify their unique skincare needs. By delivering personalized insights, Sequential Skin empowers individuals to make informed decisions about their skincare routines.

Intelligent Implants is a bioelectronics company developing an implantable electrical stimulation platform that uses wireless devices to stimulate, steer, and monitor bone growth and tissue recovery. The company designs electrotherapeutic medical devices intended to treat diseases and accelerate healing in bone and other tissues. Its implants enable healthcare providers to control and monitor treatment, supporting decision making in patient care. By integrating data, engineering and medicine, Intelligent Implants aims to bring active, connected medical devices to clinical practice, improving outcomes for individuals with bone conditions and related injuries.

AnimalBiome specializes in personalized pet nutrition, focusing on improving gut health for dogs and cats through microbiome science. The company offers microbiome tests to analyze pets' gut bacteria and provides tailored restorative supplements sourced from healthy animals to balance the microbiome.

Neurode develops a non-invasive wearable headset and companion software to treat and monitor ADHD-related symptoms by delivering electrical stimulation to balance brain activity, targeting cognitive functions such as working memory, attention, and impulse control. The drug-free approach supports medical professionals in improving cognitive performance, while the paired app tracks progress and shares data with clinicians for ongoing assessment and adjustment of treatment.

BiomeSense develops an integrated hardware, software, and data platform to scale microbiome data collection and analysis for clinical research. The company integrates at-home monitoring of the gut microbiome through its GutLab smart-bathroom system with the MetaBiome time-series analytics platform to connect microbiome changes with clinical outcomes in real time. Its platform supports large-scale, densely longitudinal datasets to discover, validate, and commercialize microbiome biomarkers, enabling clinicians to apply microbiome insights to improve human health. Founded in 2018 and based in Chicago, BiomeSense seeks to advance precision medicine by providing end-to-end microbiome measurement and analytics.

SAVA develops advanced biosensing technology for painless, real-time, and affordable health monitoring. Their innovative solutions enable continuous tracking of glucose and lactate levels, empowering users with real-time bodily insights to optimize performance and nutrition.

XXICO is a platform consisting of devices and software that enable remote health monitoring.

Harae Dx Corp. is a medical diagnostics company that has created a compact and portable multi-cancer detection system. This innovative platform enables automated cancer diagnostics by detecting cancer biomarkers directly, eliminating the need to send specimens to third-party laboratories. By reducing the potential for human processing errors and improving turnaround times for results, Harae Dx's technology allows healthcare professionals to identify and treat cancer at an early stage more effectively and affordably.

Neurocess develops wearable technology designed to enhance athletic performance and reduce injury risks. Their product attaches sensors to monitor muscle signals during training sessions, providing valuable insights like muscle balance, fatigue levels, and dehydration status to coaches and athletes.

Kite Medical, established in 2016 and headquartered in Galway, Ireland, specializes in the manufacture of a non-invasive, wearable device for detecting kidney reflux in children with urinary tract infections. This innovative solution aims to replace complex procedures and hospital visits, benefiting both patients and healthcare providers. The device targets a prevalent condition affecting up to 3% of young children, helping in early detection and preventing potential long-term kidney damage.

Free to Feed is a company focused on enhancing breastfeeding experiences by providing solutions for detecting food allergens in breast milk. It offers an innovative over-the-counter allergen test that empowers breastfeeding mothers to identify various food proteins in their milk, which is crucial for those concerned about potential infant food allergies or intolerances. The company’s patented testing kits, combined with a mobile application, allow mothers to document the presence of allergens, the timing of milk expression, and any symptoms their infants may exhibit. This comprehensive data collection aids medical professionals in diagnosing and managing food allergies effectively. With a growing recognition of the importance of early allergen introduction to mitigate future allergies, Free to Feed supports parents in navigating these complexities with tailored counseling and technology, ensuring they can confidently meet their breastfeeding goals while safeguarding their infants' health.

Dalton Bioanalytics is a company that specializes in analytical technology aimed at transforming blood analysis and enhancing preventative healthcare. Founded in 2019 and based in Los Angeles, California, Dalton Bioanalytics addresses the inefficiencies and high costs associated with traditional laboratory testing. Its innovative technology digitizes the biochemical composition of blood, allowing for a comprehensive array of health insights derived from a single assay. This capability enables the monitoring of various plasma analytes, including proteins, lipids, electrolytes, and small molecules. By deciphering the biochemical signatures in blood, Dalton Bioanalytics supports the scientific research community in exploring multi-omic biology, thereby facilitating the discovery, development, and delivery of precision medicine.

Sequential Skin is a diagnostic platform focused on skin longevity and aging, leveraging expertise in genetics, epigenetics, and the skin microbiome. The company specializes in clinical microbiome testing for skin, scalp, and female health. Its primary offering is a skin health test that employs quantitative real-time PCR (qPCR) technology to analyze specific markers within the skin microbiome. This analysis provides individuals with a detailed understanding of their skin profile, helping them identify their unique skincare needs. By delivering personalized insights, Sequential Skin empowers individuals to make informed decisions about their skincare routines.

PhableCare creates an ecosystem of patients, doctors, hospitals, health devices, insurance, and patient care service providers. In India, 1 in 4 people suffer from chronic ailments. Meanwhile, 80% of patients cannot comply to the treatment plan provided by the doctor leading to even more complications. This poses a huge burden on the healthcare system. Phable solves this by making care autonomous and predictive. Our AI-enabled health assistant significantly improves health outcomes by enabling disease-specific guidance and continuous monitoring.